Buscar
Mostrando ítems 1-10 de 39
Preoperative somatostatin analogues versus direct transsphenoidal surgery for newly-diagnosed acromegaly patients: a systematic review and meta-analysis using the GRADE system
(Springer, 2015-08-01)
Whether the preoperative use of somatostatin analogues (SA) improves surgical outcomes in acromegaly is still a matter of debate.We conducted a systematic review of randomized, controlled trials that compared the short-term ...
Cost-effectiveness analysis of somatostatin analogues in the treatment of acromegaly in Brazil
(Sociedade Brasileira de Endocrinologia e Metabologia, 2008)
This study aims to compare economic and patient impacts of the treatment of acromegaly with two different somatostatin analogues (octreotide LAR and lanreotide SR) in Brazil. A cost-effectiveness analysis was carried out ...
Cost-effectiveness analysis of somatostatin analogues in the treatment of acromegaly in Brazil
(Sociedade Brasileira de Endocrinologia e Metabologia, 2008-12-01)
This study aims to compare economic and patient impacts of the treatment of acromegaly with two different somatostatin analogues (octreotide LAR and lanreotide SR) in Brazil. A cost-effectiveness analysis was carried out ...
Management of Neuroendocrine Tumors: A Meeting of Experts from Latin America
(KARGER, 2008)
A panel of experts from Latin America convened in Brazil, in May of 2007, for consensus recommendations regarding the management of neuroendocrine tumors ( NETs) of the gastrointestinal tract and pancreas. The recently ...
Management of acromegaly in Latin America: expert panel recommendations
(SPRINGER, 2010)
Although there are international guidelines orienting physicians on how to manage patients with acromegaly, such guidelines should be adapted for use in distinct regions of the world. A panel of neuroendocrinologists ...